Topotecan and cladribine with filgrastim support in relapsed, refractory and poor prognosis leukemias: A phase I-II study

被引：0
|
作者：
Silverman, LR [1 ]
Isola, L [1 ]
Brenner, R [1 ]
Gabrilove, J [1 ]
Mandeli, J [1 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6724
引用
收藏
页码：613S / 613S
页数：1
相关论文
共 50 条
  • [1] Phase I study of bortezomib in refractory or relapsed acute leukemias
    Cortes, J
    Thomas, D
    Koller, C
    Giles, F
    Estey, E
    Faderl, S
    Garcia-Manero, G
    McConkey, D
    Patel, G
    Guerciolini, R
    Wright, J
    Kantarjian, H
    CLINICAL CANCER RESEARCH, 2004, 10 (10) : 3371 - 3376
  • [2] Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer
    Heist, Rebecca Suk
    Fain, Jerry
    Chinnasami, Bernard
    Khan, Waseem
    Molina, Julian R.
    Sequist, Lecia V.
    Temel, Jennifer S.
    Fidias, Panos
    Brainerd, Valari
    Leopold, Lance
    Lynch, Thomas J.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1637 - 1643
  • [3] Phase I study of sorafenib in patients with refractory or relapsed acute leukemias
    Borthakur, Gautam
    Kantarjian, Hagop
    Ravandi, Farhad
    Zhang, Weiguo
    Konopleva, Marina
    Wright, John J.
    Faderl, Stefan
    Verstovsek, Srdan
    Mathews, Sheela
    Andreeff, Michael
    Cortes, Jorge E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01): : 62 - 68
  • [4] Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias
    Giles, FJ
    Faderl, S
    Thomas, DA
    Cortes, JE
    Garcia-Manero, G
    Douer, D
    Levine, AM
    Koller, CA
    Jeha, SS
    O'Brien, SM
    Estey, EH
    Kantarjian, HM
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 1050 - 1056
  • [5] Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma
    Kraut, EH
    Young, D
    Farag, S
    James, AG
    Solove, RJ
    LEUKEMIA RESEARCH, 2005, 29 (10) : 1233 - 1234
  • [6] A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer
    Hussain, SA
    Moffitt, DD
    Glaholm, JG
    Peake, D
    Wallace, DMA
    James, ND
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 929 - 935
  • [7] A MULTICENTER PHASE I-II STUDY OF TOSEDOSTAT IN THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
    Ossenkoppele, G.
    Hooftman, W.
    Zweegman, S.
    Davies, E.
    Morgan, G.
    Mueller-Tidow, C.
    Krug, U.
    Duhrsen, U.
    Burnett, A.
    Jenkins, C.
    Zachee, P.
    Dierickx, D.
    Lowenberg, B.
    Sonneveld, P.
    Hooftman, L.
    Richardson, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 429 - 429
  • [8] Phase II Study of Bortezomib, Mitoxantrone and Etoposide In Relapsed/Refractory Acute Leukemias
    Filicko-O'Hara, Joanne
    Mookerjee, Bijoyesh
    Alpdogan, Onder
    Besa, Emmanuel C.
    Carabasi, Matthew
    Gitelson, Elena
    Kasner, Margaret
    Wagner, John L.
    Weiss, Mark
    Flomenberg, Neal
    BLOOD, 2010, 116 (21) : 904 - 905
  • [9] Phase I and pharmacologic study of infusional topotecan and carboplatin in relapsed and refractory acute leukemia
    Kaufmann, SH
    Karp, JE
    Letendre, L
    Kottke, TJ
    Safgren, S
    Greer, J
    Gojo, I
    Atherton, P
    Svingen, PA
    Loegering, DA
    Litzow, MR
    Sloan, JA
    Reid, JM
    Ames, MM
    Adjei, AA
    Erlichman, C
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6641 - 6649
  • [10] Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies
    Rubnitz, JE
    Razzouk, BI
    Srivastava, DK
    Pui, CH
    Ribeiro, RC
    Santana, VM
    LEUKEMIA RESEARCH, 2004, 28 (04) : 349 - 352
12345